CD79A and pneumococcal bacteremia: We have shown the superiority of intranasal immunization with Pnc1-TT and LT-K63 in neonatal and infant mice compared to parenteral immunization, in terms of enhanced specific mucosal IgA and systemic IgG and protection from pneumococcal bacteremia and lung infection (13).